Otofarma S.P.A. Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	2.1	0.75
Depreciation & Amortization	0.06	0.05
Other Amortization	0.07	-
Other Operating Activities	0.38	0.3
Change in Accounts Receivable	-0.1	-0.76
Change in Inventory	-0.11	-0.07
Change in Accounts Payable	0.09	0.6
Change in Other Net Operating Assets	-0.26	-0.46
Operating Cash Flow	2.24	0.42
Operating Cash Flow Growth	437.75%	-
Capital Expenditures	-0.23	-0.03
Sale (Purchase) of Intangibles	-0.68	0.01
Investment in Securities	-0	-0
Investing Cash Flow	-0.91	-0.02
Short-Term Debt Issued	0.08	0.03
Long-Term Debt Issued	0.09	-
Total Debt Issued	0.17	0.03
Long-Term Debt Repaid	-	-0.44
Net Debt Issued (Repaid)	0.17	-0.41
Common Dividends Paid	-	-0
Other Financing Activities	0	-
Financing Cash Flow	0.17	-0.41
Net Cash Flow	1.5	-0.02
Free Cash Flow	2.01	0.39
Free Cash Flow Growth	414.71%	-
Free Cash Flow Margin	13.98%	3.86%
Levered Free Cash Flow	1.12	-
Unlevered Free Cash Flow	1.19	-
Cash Income Tax Paid	0.62	0.19
Change in Working Capital	-0.37	-0.69